Veradigm EBITDA 2010-2022 | MDRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Veradigm ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Veradigm ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.7B
Hims & Hers Health (HIMS)	$13B
Doximity (DOCS)	$11.5B
Tempus AI (TEM)	$11.2B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.9B
Hinge Health (HNGE)	$3.7B
Privia Health (PRVA)	$2.5B
Clover Health Investments (CLOV)	$1.7B
Schrodinger (SDGR)	$1.7B
10x Genomics (TXG)	$1.7B
Phreesia (PHR)	$1.6B
Enovis (ENOV)	$1.6B
Azenta (AZTA)	$1.6B
Omnicell (OMCL)	$1.3B
Evolent Health (EVH)	$1.2B
Claritev (CTEV)	$719M
Fulgent Genetics (FLGT)	$575M
Standard BioTools (LAB)	$551M
Butterfly Network (BFLY)	$532M
Talkspace (TALK)	$438M
TruBridge (TBRG)	$347M
Outset Medical (OM)	$345M
Health Catalyst (HCAT)	$282M
Nyxoah SA (NYXH)	$265M
SOPHiA GENETICS SA (SOPH)	$241M
CapsoVision (CV)	$197M
Zepp Health (ZEPP)	$176M
KORU Medical Systems (KRMD)	$164M
Pulmonx (LUNG)	$152M